https://www.selleckchem.com/pr....oducts/lazertinib-yh
ications. Response rates were significantly improved by the addition of bevacizumab. Current reports on the prognostic and predictive value of hypoxia-inducible factor-1α (HIF-1α) in endometrial carcinoma are inconsistent. Therefore, we conducted this meta-analysis to precisely evaluate the association of HIF-1α expression with susceptibility, clinical features, and prognosis of endometrial cancer. Eligible studies that assessed the role of HIF-1α protein expression, immunohistochemistry detection, disease susceptibi
Like
Comment
Share
